Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus
Background Human papillomavirus (HPV)‐positive cases of squamous cell carcinoma of the head and neck (SCCHN) have a much better disease outcome compared to SCCHN cases lacking HPV. Differences in microRNA (miRNA) expression may affect their clinical outcomes. Methods The miRNA expression was studied...
Gespeichert in:
Veröffentlicht in: | Head & neck 2011-04, Vol.33 (4), p.504-512 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Human papillomavirus (HPV)‐positive cases of squamous cell carcinoma of the head and neck (SCCHN) have a much better disease outcome compared to SCCHN cases lacking HPV. Differences in microRNA (miRNA) expression may affect their clinical outcomes.
Methods
The miRNA expression was studied using microarrays and quantitative reverse transcriptase‐polymerase chain reaction (RT‐PCR) in HPV‐16‐positive and HPV‐negative SCCHN cell lines. The role of HPV‐16 E6 and E7 oncogenes in altering miRNA expression was investigated using human foreskin keratinocytes (HFKs).
Results
The miRNAs miR‐363, miR‐33, and miR‐497 were upregulated, whereas miR‐155, miR‐181a, miR‐181b, miR‐29a, miR‐218, miR‐222, miR‐221, and miR‐142‐5p were downregulated in HPV‐positive cells compared to both HPV‐negative SCCHN and normal oral keratinocytes. HPV‐16 E6 oncogene altered miRNA expression in HFKs and in an HPV‐16–positive cell line with E6 knockdown using siRNA.
Conclusion
miRNAs differentially expressed in the presence of HPV‐16 may provide biomarkers for SCCHN and identify cellular pathways targeted by this virus. © 2010 Wiley Periodicals, Inc. Head Neck, 2011 |
---|---|
ISSN: | 1043-3074 1097-0347 1097-0347 |
DOI: | 10.1002/hed.21475 |